Comprehensive Overview of Vaccination during Pregnancy in Europe
Vaccinations during pregnancy can protect the mother from several infections, thus blocking vertical transmission. Furthermore, through passive antibody transfer, the newborn can be protected against some infections in the first months of life until their own vaccination regimen is initiated and com...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c65f7c0d01794e8385fc6fbfeb2b5053 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c65f7c0d01794e8385fc6fbfeb2b5053 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c65f7c0d01794e8385fc6fbfeb2b50532021-11-25T18:07:56ZComprehensive Overview of Vaccination during Pregnancy in Europe10.3390/jpm111111962075-4426https://doaj.org/article/c65f7c0d01794e8385fc6fbfeb2b50532021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4426/11/11/1196https://doaj.org/toc/2075-4426Vaccinations during pregnancy can protect the mother from several infections, thus blocking vertical transmission. Furthermore, through passive antibody transfer, the newborn can be protected against some infections in the first months of life until their own vaccination regimen is initiated and completed at the appropriate age. Pregnancy can be considered a high-risk condition that increases vulnerability to infectious diseases with potentially unfavorable evolution. We present the current knowledge on vaccination during pregnancy in Europe as a useful information source for different health workers involved in prenatal care. Many European countries implement vaccination policies specifically designed for pregnant women, but there is great heterogeneity among programs. Recommendations on vaccination during pregnancy must be based on current high-quality scientific data. The decisions must be made for each individual case, depending on the associated conditions or special circumstances, with a concomitant assessment of the potential benefits and risks to both the pregnant patient and the fetus. Many vaccines are well-tolerated in pregnant women, with no clinically meaningful injection site reactions, systemic symptoms, or vaccine-related serious adverse events.Anca Angela SimionescuAnca Streinu-CercelFlorin-Dan PopescuAna Maria Alexandra StanescuMariana VieruBianca Mihaela DanciuVictor Daniel MironOana SăndulescuMDPI AGarticlepregnancyvaccinesEuropeMedicineRENJournal of Personalized Medicine, Vol 11, Iss 1196, p 1196 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
pregnancy vaccines Europe Medicine R |
spellingShingle |
pregnancy vaccines Europe Medicine R Anca Angela Simionescu Anca Streinu-Cercel Florin-Dan Popescu Ana Maria Alexandra Stanescu Mariana Vieru Bianca Mihaela Danciu Victor Daniel Miron Oana Săndulescu Comprehensive Overview of Vaccination during Pregnancy in Europe |
description |
Vaccinations during pregnancy can protect the mother from several infections, thus blocking vertical transmission. Furthermore, through passive antibody transfer, the newborn can be protected against some infections in the first months of life until their own vaccination regimen is initiated and completed at the appropriate age. Pregnancy can be considered a high-risk condition that increases vulnerability to infectious diseases with potentially unfavorable evolution. We present the current knowledge on vaccination during pregnancy in Europe as a useful information source for different health workers involved in prenatal care. Many European countries implement vaccination policies specifically designed for pregnant women, but there is great heterogeneity among programs. Recommendations on vaccination during pregnancy must be based on current high-quality scientific data. The decisions must be made for each individual case, depending on the associated conditions or special circumstances, with a concomitant assessment of the potential benefits and risks to both the pregnant patient and the fetus. Many vaccines are well-tolerated in pregnant women, with no clinically meaningful injection site reactions, systemic symptoms, or vaccine-related serious adverse events. |
format |
article |
author |
Anca Angela Simionescu Anca Streinu-Cercel Florin-Dan Popescu Ana Maria Alexandra Stanescu Mariana Vieru Bianca Mihaela Danciu Victor Daniel Miron Oana Săndulescu |
author_facet |
Anca Angela Simionescu Anca Streinu-Cercel Florin-Dan Popescu Ana Maria Alexandra Stanescu Mariana Vieru Bianca Mihaela Danciu Victor Daniel Miron Oana Săndulescu |
author_sort |
Anca Angela Simionescu |
title |
Comprehensive Overview of Vaccination during Pregnancy in Europe |
title_short |
Comprehensive Overview of Vaccination during Pregnancy in Europe |
title_full |
Comprehensive Overview of Vaccination during Pregnancy in Europe |
title_fullStr |
Comprehensive Overview of Vaccination during Pregnancy in Europe |
title_full_unstemmed |
Comprehensive Overview of Vaccination during Pregnancy in Europe |
title_sort |
comprehensive overview of vaccination during pregnancy in europe |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/c65f7c0d01794e8385fc6fbfeb2b5053 |
work_keys_str_mv |
AT ancaangelasimionescu comprehensiveoverviewofvaccinationduringpregnancyineurope AT ancastreinucercel comprehensiveoverviewofvaccinationduringpregnancyineurope AT florindanpopescu comprehensiveoverviewofvaccinationduringpregnancyineurope AT anamariaalexandrastanescu comprehensiveoverviewofvaccinationduringpregnancyineurope AT marianavieru comprehensiveoverviewofvaccinationduringpregnancyineurope AT biancamihaeladanciu comprehensiveoverviewofvaccinationduringpregnancyineurope AT victordanielmiron comprehensiveoverviewofvaccinationduringpregnancyineurope AT oanasandulescu comprehensiveoverviewofvaccinationduringpregnancyineurope |
_version_ |
1718411584023298048 |